Insight certainty 4/5 debate potential 2/5

Solomon: Humans lack the intuition to analyze high-dimensional biological data

Noam Solomon · HIBT Lab! Immunai: Noam Solomon · Dec 22, 2022 · at 28:40

Immunai co-founder and CEO Noam Solomon discusses why AI is necessary to analyze the massive complexity of human immune system data compared to human intuition.

0:00 / 0:09exact quote · 9.5s
720p mp4 · rendered on demand · StarZero watermark
“No human being will have the intuition to analyze all the relevant data. You have to use a machine to analyze the data.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Noam Solomon

Prediction Not checkable as stated
Solomon: Immune system mapping enables data-driven drug discovery
“Having a map of the human immune system will enable researchers to apply data mining tools to come up with novel ways to develop and discover therapeutics.”
Noam Solomon Dec 22, 2022 ▶ 7:04 HIBT Lab! Immunai: Noam Solomon
Prediction Not checkable as stated
Solomon predicts immune profiling will enable preventative healthcare within 15 years
“The vision that I have and the hope that I have is that maybe in 15 years, We'll be able to use our new profile and capabilities to help people remain healthy.”
Noam Solomon Dec 22, 2022 ▶ 9:44 HIBT Lab! Immunai: Noam Solomon
Opinion
Solomon: Bridging animal testing to humans is biotech's biggest challenge
“Understanding how to bridge the gap between the human immune response and the way that drugs are being tested in animal models. Is, I believe, the biggest challenge that the biopharma and biotechnology industry should face and will face in the coming, ah, deca…”
Noam Solomon Dec 22, 2022 ▶ 11:07 HIBT Lab! Immunai: Noam Solomon
Assertion Not checkable as stated
Solomon: Immunai's database spans over 100,000 patients across 500 diseases
“It is the largest of its kind database of the immune system with a single cell resolution. So today we have a database that spans over 100,000 patients, over 500 different disease indications, thousands of studies, and we're trying to put as much clinical cont…”
Noam Solomon Dec 22, 2022 ▶ 17:39 HIBT Lab! Immunai: Noam Solomon
Assertion Not checkable as stated
Solomon: Immunai's platform successfully identifies superior clinical drug combinations
“We were able to show quite definitively that our platform can identify the preferred combination arm that will demonstrate a superior immune response. So it happened already.”
Noam Solomon Dec 22, 2022 ▶ 18:34 HIBT Lab! Immunai: Noam Solomon
Assertion Not checkable as stated
Solomon founded Immunai knowing nothing about biology, medicine, or business
“I started the company. I didn't know anything about biology, medicine, business development, and I had to ask a lot of questions”
Noam Solomon Dec 22, 2022 ▶ 26:17 HIBT Lab! Immunai: Noam Solomon
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 800 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.